{"url_path":"/sec/orka/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/907654/0001213900-26-055769-index.html","accession_number":"0001213900-26-055769","cik":"0000907654","ticker":"ORKA","issuer_name":"Oruka Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/907654/0001213900-26-055769-index.html","primary_entity_key":"0000907654","primary_entity_name":"Oruka Therapeutics, Inc."},"word_count":64,"has_tables":true,"body_markdown":"**Item 1. Legal Proceedings**\n\n \n\nFrom time to time, we may\nbecome involved in legal proceedings relating to claims arising from the ordinary course of business. Our management believes that there\nare currently no claims or actions pending against us, the ultimate disposition of which could reasonably be expected to have a material\nadverse effect on our results of operations, financial condition or cash flows."}